ストックスクリーナーアプリを入手
877.66
2.08%
-19.34
アフターアワーズ：
877.00
-0.66
-0.08%
Lilly Eli Co (LLY) 最新ニュース
Eli Lilly Stock (LLY) Gets a Boost From Latest Trial Results. It Has Nothing to Do with Obesity Drugs - TipRanks
MDGL Stock Surges Most In A Month On Eli Lilly Buyout Speculation - Stocktwits
Judge Advances Lilly Suit Over Online Platforms’ Mounjaro Copies - Bloomberg Law News
Eli Lilly stock price forecast: bears dominate as LLY consolidates near 200-day support - Traders Union
Clark Foundation, Lilly to partner on new downtown basketball court - Indiana Economic Digest
Morgan Stanley reiterates Overweight on Eli Lilly stock, $1,313 target By Investing.com - Investing.com India
Jefferies reiterates Buy on Eli Lilly stock, $1,300 target - Investing.com
Lilly’s Ebglyss shows four-year efficacy in eczema study - Investing.com
Erste Group Bank Raises Eli Lilly's FY2027 Earnings Forecast - National Today
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis - PR Newswire
AI Models Split on Eli Lilly: Strong Fundamentals, Premium Valuation - TipRanks
Pensionfund Sabic Buys $1.83M Stake in Eli Lilly - National Today
Pensionfund Sabic Makes New Investment in Eli Lilly and Company - National Today
Institutional Investors Are Selling One of Wall Street's Premier Trillion-Dollar Club Members (No, Not Nvidia!) - The Motley Fool
Bath Savings Trust Co Boosts Stake in Eli Lilly - National Today
MDGL stock surges most in a month on Eli Lilly buyout speculation - MSN
Vanguard disaggregation: Eli Lilly (NYSE: LLY) ownership shows 0 shares - Stock Titan
Why is Eli Lilly stock down today? - Traders Union
The Bull Case For Eli Lilly (LLY) Could Change Following Retatrutide Milestone And Governance ShiftLearn Why - simplywall.st
Eli Lilly stock price forecast: consolidation after recovery as LLY holds above long-term support - Traders Union
Eli Lilly's Sustainability in Pharmaceuticals Strategy - Sustainability Magazine
Assenagon Asset Management S.A. Decreases Stock Position in Eli Lilly and Company $LLY - MarketBeat
Sen. Angus S. King Jr. Sells Off Shares of Eli Lilly and Company (NYSE:LLY) - MarketBeat
Eli Lilly & Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Buy Eli Lilly Stock (LLY) as Employers Move to Cover Obesity Drugs, Says Morgan Stanley - TipRanks
Is Eli Lilly (LLY) The Best Healthcare Stock to Buy According to Jim Cramer? - Insider Monkey
Assessing Eli Lilly (LLY) Valuation After The Recent Share Price Pullback - simplywall.st
Eli Lilly and the ‘societal obligation’ of GLP-1s - statnews.com
AI Models Split on Eli Lilly: Strong Growth vs. Premium Valuation - TipRanks
Spartan Planning & Wealth Management Buys Shares of 1,556 Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Purchased by Dynamic Advisor Solutions LLC - MarketBeat
Biocon To Benefit After Eli Lilly Joins Novo Nordisk To Exit European Insulins Market - NDTV Profit
INNOVENT BIO-Eli Lilly Strategic Collaboration Deal Takes Effect; Rumored Acquisition Intent Not True - AASTOCKS.com
Eli Lilly to phase out select insulin products across Europe by 2027 - MSN
Workforce was region’s secret weapon in winning Eli Lilly | Opinion - PennLive.com
Martin Shkreli Says Silicon Valley's Hottest Health Obsession Is A 'Delusion' - Benzinga
Lilly Advances Next-Gen Diabetes Drug With Completed Pediatric PK Study - TipRanks
Barclays Pounds the Table on Eli Lilly Stock (LLY) as Share Price Falls - TipRanks
Top Analyst Reports for Eli Lilly, RTX & Abbott - Yahoo Finance
The Zacks Analyst Blog Highlights Eli Lilly, RTX, Abbott Laboratories, Ohio Valley Banc and Rave Restaurant - Yahoo Finance Singapore
Eli Lilly To Phase Out Select Insulin Products Across Europe By 2027 - Benzinga
Massive class action seeking RICO penalties against Takeda, Lilly presses forward with SCOTUS order - Fierce Pharma
Eli Lilly (NYSE:LLY) Sees Institutional Activity in Russell 1000 - Kalkine Media
Morgan Stanley Reiterates Overweight on Eli Lilly (LLY), Cites Growth Potential of New Platform - insidermonkey.com
Gradient Investments LLC Buys 19,634 Shares of Eli Lilly and Company $LLY - MarketBeat
Hutchens & Kramer Investment Management Group LLC Sells 3,715 Shares of Eli Lilly and Company $LLY - MarketBeat
Grove Bank & Trust Cuts Stock Position in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Stock Holdings Decreased by Sarasin & Partners LLP - MarketBeat
Nordea Investment Management AB Raises Stock Position in Eli Lilly and Company $LLY - MarketBeat
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,350 - Moomoo
Eli Lilly Stock: Analysts See 35% Upside, Driven by GLP-1 Demand and Q4 2025 ResultsNews and Statistics - IndexBox
What's going on with Eli Lilly on Monday? - MSN
Eli Lilly's diabetes drug cuts weight by 17% in trial - qz.com
Eli Lilly Weight Loss Push Weighs On Valuation And Growth Hopes - simplywall.st
Stock Quote & Chart | Eli Lilly and Company - Eli Lilly
Lilly, Amgen Seek Fast Win in Suit Over Clinics in Discount Plan - Bloomberg Law News
Eli Lilly selects Lehigh Valley for $3.5 billion life sciences plant in 2026 - Lehigh Valley Business
What's Going On With Eli Lilly On Monday? - Benzinga
Eli Lilly (LLY) Faces Negative ROE Trend Despite Promising Future - GuruFocus
Eli Lilly Stock (LLY) Faces This Make-or-Break Test on April 10 - TipRanks
U.S. executives, from Apple to Eli Lilly, revamp their push into the world's second-largest economy at the China Development Forum - CNBC
Takeda, Lilly Rejected by Supreme Court on Actos Fraud Lawsuit - Bloomberg.com
Here's How Much Upside Eli Lilly Stock Has, According to Analysts - AOL.com
0.51%
0.83%
大文字化:
|
ボリューム (24 時間):